Faida
User from
very informative about prostate cancer
Posted on 27/05/2026
Prostate Cancer: Which Therapeutic Option for Which Patient is a Continuing Professional Development (CPD) course designed for healthcare professionals working in primary care, urology, oncology, nursing, men’s health, radiology, pharmacy, and community healthcare settings. The course provides an evidence-based overview of prostate cancer screening, diagnosis, staging, risk stratification, treatment selection, and multidisciplinary management. Prostate cancer is one of the most commonly diagnosed cancers among men worldwide. Early detection and appropriate management are essential to improving patient outcomes while balancing quality of life considerations. Advances in imaging, pathology, genomics, and treatment strategies have significantly changed prostate cancer diagnosis and management pathways in recent years.
.jpg)
Stay updated with our


Stay updated with our


.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
User from
very informative about prostate cancer
Posted on 27/05/2026
Join Care Learning as a trainer and deliver high-quality courses to learners across healthcare and workplace training.
Invite healthcare professionals to join Care Learning and get rewarded when your referral successfully joins.
The prostate is a small gland in the male reproductive system located below the bladder.
A PSA test measures prostate-specific antigen levels in the blood and may help identify prostate abnormalities.
The Gleason score is a grading system used to assess prostate cancer aggressiveness based on biopsy findings.
Active surveillance involves close monitoring of low-risk prostate cancer without immediate treatment.
MRI helps identify suspicious lesions and assists in guiding prostate biopsy procedures.
Multidisciplinary care improves treatment planning, coordination, and patient-centred decision-making.